Supplemental Balance Sheet Information
|12 Months Ended|
Dec. 31, 2022
|Balance Sheet Related Disclosures [Abstract]|
|Supplemental Balance Sheet Information||Supplemental Financial Statement Information
Accounts Receivable, net
As of December 31, 2022 and December 25, 2021, Accounts receivable, net included unbilled accounts receivable of $1.1 billion and $329 million, respectively. Unbilled accounts receivables primarily represent work completed for development services and on custom products for which revenue has been recognized but not yet invoiced. All unbilled accounts receivable are expected to be billed and collected within 12 months.
Depreciation expense for 2022, 2021 and 2020 was $439 million, $296 million and $217 million, respectively.
Prepaid long-term supply agreements relate to payments made to vendors to secure long-term supply capacity.
Revenue allocated to remaining performance obligations that are unsatisfied (or partially unsatisfied) include amounts received from customers and amounts that will be invoiced and recognized as revenue in future periods for development services, IP licensing and product revenue. As of December 31, 2022, the aggregate transaction price allocated to remaining performance obligations under contracts with an original expected duration of more than one year was $247 million, of which $213 million is expected to be recognized in the next 12 months. The revenue allocated to remaining performance obligations does not include amounts which have an original expected duration of one year or less.
Revenue recognized over time associated with custom products and development services accounted for approximately 24%, 23% and 18% of the Company’s revenue in 2022, 2021 and 2020, respectively.
No definition available.
The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef